Celestis Pharmaceuticals

Ahmedabad, India
Research and development in Active Pharmaceutical Ingredients, intermediates, and impurities are conducted in India.

About Celestis Pharmaceuticals

Celestis Pharmaceuticals is an Industrial Goods & Manufacturing company based in Ahmedabad (India). Research and development in Active Pharmaceutical Ingredients, intermediates, and impurities are conducted in India. It operates in the Industrial Goods & Manufacturing and Chemicals & Materials sectors. Its Indian entity Celestis Pharmaceuticals Private Limited reported revenue of β‚Ή4.3 Lakh. Celestis Pharmaceuticals offers products and services including API and API Intermediates. Its focus areas include Healthcare, R&D Services, Chemical Research and Impurity Analysis.

Company details

Celestis Pharmaceuticals is identified as a research-driven company specializing in Active Pharmaceutical Ingredients, API intermediates, and impurities. It is noted for supplying synthetic chemistry technology to customers for API synthesis and delivering cost-effective RD solutions in API research. Expertise in synthesizing specialized small organic compounds and isolating natural products is emphasized, with an aim to operate as a dedicated RD organization focused on pharmaceutical advancements. The company maintains operations in India to support these activities.

  • Headquarters Ahmedabad, India
  • Sectors
    Industrial Goods & Manufacturing
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website celestispharma.com
  • Legal Name Celestis Pharmaceuticals Pvt. Ltd
  • Date of Incorporation 23 Jun, 2014
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹4.3 Lakh

    FY 2024 · -31% YoY

  • Net Loss
    -₹16.8 Lakh

    FY 2024 · -392% margin

  • EBITDA
    -₹13.6 Lakh

    FY 2024 · -317% margin

Products & Services of Celestis Pharmaceuticals

Celestis Pharmaceuticals offers a comprehensive portfolio of products and services, including API and API Intermediates.

API
Pharmaceutical Products

Active Pharmaceutical Ingredients are supplied for synthesis purposes, with technology provided to customers in a research-driven context

API Intermediates
Chemical Intermediates

Intermediates related to API are offered to facilitate production processes in pharmaceutical research

Board of directors of Celestis Pharmaceuticals Private Limited (Celestis Pharmaceuticals)

Celestis Pharmaceuticals Private Limited is the primary company behind Celestis Pharmaceuticals. The board of Celestis Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Mousumi Jayanta Mandal, appointed in 2014. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mousumi Jayanta Mandal
DIN 05280276
Director23 Jun 201412 yrs 4 moCelestis Pharmaceuticals Private Limited
Sunita Pravin Thombare
DIN 06828821
Director23 Jun 201412 yrs 4 moCelestis Pharmaceuticals Private Limited
Pravin Sahadev Thombare
DIN 06828772
Director23 Jun 201412 yrs 4 moCelestis Pharmaceuticals Private Limited

Financials of Celestis Pharmaceuticals

Figures of Celestis Pharmaceuticals Private Limited, the primary company behind Celestis Pharmaceuticals, for FY 2024. Revenue was ₹4.3 Lakh (-31% year on year). Net loss was -₹16.8 Lakh (-392% margin). EBITDA was -₹13.6 Lakh (-317% margin). Revenue has grown at a compounded annual rate of -41% over three years and -40% over five years.

  • ₹4.3 LakhRevenue · FY 2024 · -31% YoY
  • -₹16.8 LakhNet loss · -392% margin
  • -₹13.6 LakhEBITDA · -317% margin
  • ₹13.8 LakhPaid-up capital
  • -41%Revenue CAGR, 3 years
  • -40%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Celestis Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Celestis Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Celestis Pharmaceuticals

Celestis Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Celestis Pharmaceuticals, Celestis Pharmaceuticals Private Limited, reported revenue of β‚Ή4.3 Lakh for FY 2024, down 31% year on year.

Celestis Pharmaceuticals is identified as a research-driven company specializing in Active Pharmaceutical Ingredients, API intermediates, and impurities. It is noted for supplying synthetic chemistry technology to customers for API synthesis and delivering cost-effective RD solutions in API research. Expertise in synthesizing specialized small organic compounds and isolating natural products is emphasized, with an aim to operate as a dedicated RD organization focused on pharmaceutical advancements. The company maintains operations in India to support these activities.

Celestis Pharmaceuticals offers API and API Intermediates.

Celestis Pharmaceuticals operates through Celestis Pharmaceuticals Private Limited.

The legal entities of Celestis Pharmaceuticals currently have 3 directors, including Mousumi Jayanta Mandal, Sunita Pravin Thombare, Pravin Sahadev Thombare.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available